0.8(top 50%)
impact factor
218(top 50%)
papers
1.8K(top 50%)
citations
17(top 50%)
h-index
1.1(top 50%)
impact factor
276
all documents
1.9K
doc citations
36(top 20%)
g-index

Top Articles

#TitleJournalYearCitations
1Radiomics: a new application from established techniquesExpert Review of Precision Medicine and Drug Development2016262
2The role of artificial intelligence in precision medicineExpert Review of Precision Medicine and Drug Development2017185
3Deep learning and radiomics in precision medicineExpert Review of Precision Medicine and Drug Development2019151
4The economic case for precision medicineExpert Review of Precision Medicine and Drug Development201866
5The role of epigenomics in personalized medicineExpert Review of Precision Medicine and Drug Development201761
6Use of big data in drug development for precision medicine: an updateExpert Review of Precision Medicine and Drug Development201951
7Drug repositioning: current approaches and their implications in the precision medicine eraExpert Review of Precision Medicine and Drug Development201848
8Current approaches and future perspectives on strategies for the development of personalized tissue engineering therapiesExpert Review of Precision Medicine and Drug Development201643
9The path from big data to precision medicineExpert Review of Precision Medicine and Drug Development201637
10Efficacy of lumacaftor-ivacaftor for the treatment of cystic fibrosis patients homozygous for the F508del-CFTR mutationExpert Review of Precision Medicine and Drug Development201634
11Use of big data in drug development for precision medicineExpert Review of Precision Medicine and Drug Development201628
12Patient-derived organoid analysis of drug resistance in precision medicine: is there a value?Expert Review of Precision Medicine and Drug Development202026
13Implementation of next generation sequencing in clinical molecular diagnostic laboratories: advantages, challenges and potentialExpert Review of Precision Medicine and Drug Development201625
14TRAIL pathway targeting therapeuticsExpert Review of Precision Medicine and Drug Development201824
15Privacy and ethical challenges in next-generation sequencingExpert Review of Precision Medicine and Drug Development201922
16Tackling pharmacological response heterogeneity by PBPK modeling to advance precision medicine productivity of nanotechnology and genomics therapeuticsExpert Review of Precision Medicine and Drug Development201921
17Tissue-based biomarkers in prostate cancerExpert Review of Precision Medicine and Drug Development201720
18Precision Dosing in ChildrenExpert Review of Precision Medicine and Drug Development201618
19Big data, artificial intelligence, and cardiovascular precision medicineExpert Review of Precision Medicine and Drug Development201818
20Applications of digital PCR in precision medicineExpert Review of Precision Medicine and Drug Development201717
21Coronary artery disease genetic risk awareness motivates heart health behaviors in the Coriell Personalized Medicine CollaborativeExpert Review of Precision Medicine and Drug Development201616
22The value of genetic risk scores in precision medicine for diabetesExpert Review of Precision Medicine and Drug Development201815
23Pharmacogenomics of drugs used to treat brain disordersExpert Review of Precision Medicine and Drug Development202015
24The role of metabolomics in precision medicineExpert Review of Precision Medicine and Drug Development201613
25‘You-on-a-chip’ for precision medicineExpert Review of Precision Medicine and Drug Development201813
26Pharmacogenomic studies of hypertension: paving the way for personalized antihypertensive treatmentExpert Review of Precision Medicine and Drug Development201813
27Nab-paclitaxel and atezolizumab for the treatment of PD-L1-positive, metastatic triple-negative breast cancer: review and future directionsExpert Review of Precision Medicine and Drug Development202013
28Disease modifying anti-rheumatic drugs in juvenile idiopathic arthritis: striving for individualized therapyExpert Review of Precision Medicine and Drug Development201612
29Precision medicine for multiple sclerosis: an update of the available biomarkers and their use in therapeutic decision makingExpert Review of Precision Medicine and Drug Development201712
30Population-level pharmacogenomics for precision drug development in dementiaExpert Review of Precision Medicine and Drug Development201812
31Givosiran, a novel treatment for acute hepatic porphyriasExpert Review of Precision Medicine and Drug Development202112
32Math, magnets, and medicine: enabling personalized oncologyExpert Review of Precision Medicine and Drug Development202112
33Detecting and targeting NTRK gene fusions in cholangiocarcinoma: news and perspectivesExpert Review of Precision Medicine and Drug Development202112
34Personalized medicine in rheumatoid arthritis: methotrexate polyglutamylation revisitedExpert Review of Precision Medicine and Drug Development201811
35Slotting metabolomics into routine precision medicineExpert Review of Precision Medicine and Drug Development202111
36The use of blood biomarkers in precision medicine for the primary prevention of atherosclerotic cardiovascular disease: a reviewExpert Review of Precision Medicine and Drug Development202111
37Challenges for omics technologies in the implementation of personalized medicineExpert Review of Precision Medicine and Drug Development201810
38Proteome-based pathology: the next frontier in precision medicineExpert Review of Precision Medicine and Drug Development202110
39Technological advances in precision medicine and drug developmentExpert Review of Precision Medicine and Drug Development20169
40Towards precision medicine in Alzheimer’s disease: deciphering genetic data to establish informative biomarkersExpert Review of Precision Medicine and Drug Development20179
41Recent progress in the use and tracking of transplanted islets as a personalized treatment for type 1 diabetesExpert Review of Precision Medicine and Drug Development20179
42Personalized peptide vaccines for cancer therapy: current progress and state of the artExpert Review of Precision Medicine and Drug Development20179
43Biosensors and personalized drug therapy: what does the future hold?Expert Review of Precision Medicine and Drug Development20179
44Human regulatory T cells (Treg) and their response to cancerExpert Review of Precision Medicine and Drug Development20199
45Personalizing cognitive-behavioral treatment for pediatric obsessive-compulsive disorderExpert Review of Precision Medicine and Drug Development20168
46Personalized management of asthma exacerbations: lessons from genetic studiesExpert Review of Precision Medicine and Drug Development20168
47Non-small cell lung cancer biomarkers and targeted therapy - two faces of the same coin fostered by nanotechnologyExpert Review of Precision Medicine and Drug Development20168
48Pharmacogenetic studies of drug response in schizophreniaExpert Review of Precision Medicine and Drug Development20168
49The role of the MET/AXL pathway as a new target for multikinase inhibitors in renal cell carcinomaExpert Review of Precision Medicine and Drug Development20178
50Impact of NCI-MATCH: a Nationwide Oncology Precision Medicine TrialExpert Review of Precision Medicine and Drug Development20198